Hvivo Share Discussion Threads

[yump] 19/4/2024 11:51

I wonder what its like to be like one of Pavlov’s dogs, so you can’t resist posting on a thread, given any sort of prompt.

[chica1] 19/4/2024 10:16

35p reiterated by Stifel

[baldrick1] 19/4/2024 10:04

Yes, but I sold out at 28.25p from 26.50p ..just worried about losing the profit built up .Would really like to get in again cheaper than 26p...I have no doubt it will get to 33p short term.:)

[chica1] 19/4/2024 09:47

Baldy behave!
Didn't u say a few weeks ago that you live close to Canary Wharf,that you checked out the new facility,were very impressed and you're now in for the long haul?

[baldrick1] 19/4/2024 08:34

Would this be a buy again at 25p??

[pgaffney] 18/4/2024 10:50

Debt debt and more debt APH

[blackhorse23] 18/4/2024 10:24

AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION

[lauders] 17/4/2024 05:06

New Business Development Director.

[chica1] 16/4/2024 18:32

Well the dividend was very very nominal and probably disappointed.
They only gave shareholders the interest they received on cash deposits,which is very stingy.
€3.1 million in 2023 v's £1.4 in 2024.Institutions like steady and growing dividends.

It'll hardly attract institutions before April 19th.
Maybe they have something earmarked to acquire later in the year.

[digger2779] 16/4/2024 13:04

I suppose this will drop another smidge when it goes ex divi. I anticipate there being another contract announcement in the pipeline prior to the AGM..IMO

[discojames] 15/4/2024 08:06

Internal accounting only, money owed by and to parent company from its own subsidiaries

[dan_the_epic] 15/4/2024 07:12

What is this all about at the back of the annual report?

"Company
During the year the Company absorbed net management charges of £344,000 (2022: £142,000) from its subsidiaries.
At 31 December 2023 the Company was owed £11,874,000 (2022: £11,280,000) by its subsidiaries, and the Company
owed £2,890,000 (2022: nil) to its subsidiaries. The Company holds a provision of £10,428,000 against the receivable."

[sikhthetech] 14/4/2024 20:34

Chica,

I had 1st, 2nd and 5th...
Great GN week.

HVO still lacking the strong revenue/order book growth...

[chica1] 13/4/2024 12:21

Think Gavin Cromwell will win the National.
Can't decide what horse😃

NOT🤪

[sikhthetech] 12/4/2024 16:44

The results and presentation were as expected.
The reaction says it all.

The growth rate has slowed significantly, as my previous assertion and evidenced by the results.

The Chairman/founder dumped majority of his holding at 28p in a discounted secondary placing. As Chairman, he obviously knew what was in the results and presentation.

The CEO has huge 7m options.

[lfdkmp] 11/4/2024 16:32

Not wishing to pick you up on what might be a (modern) figure of speech, KPE, but with some of these posters there is nothing "random" about their modus operandi.
In fact it is calculated, sustained and often cynically contrived.

I have often speculated that they must be paid for each post.

[kpe] 11/4/2024 16:14

We all seem to speak of the idiots that post random, broken record comments but let's not forget the members who contribute informative info. Big shout out.

[inaminute] 11/4/2024 16:09

Exactly. ADVFN will not realise what they are losing until it is too late. Amateurish business strategy

[lfdkmp] 11/4/2024 15:56

Yes KPE
Sadly the new beginning never really began.
Such is the sorry state now of ADVFN.

[666james] 11/4/2024 14:28

Oh no, they are here again. Why don't you buzz off

[sikhthetech] 11/4/2024 13:47

Baldrick, TLY has a diversified business model, treating millions of patients.
Revenues H1 were £55m, which is similar to HVO's fy2023.
TLY Mcap £8m, whereas HVO £197m


My assertion is HVO's business model is questionable.

HVO CEO has 7m options for a reason - to talk up the company.